Drug profile · INN
oxaprozin potassium
DAYPRO ALTA
oxaprozin potassium (DAYPRO ALTA) is a cyclooxygenase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — oxaprozin potassium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
oxaprozin potassium (DAYPRO ALTA) is a cyclooxygenase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is oxaprozin potassium?
oxaprozin potassium (DAYPRO ALTA) is a cyclooxygenase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for oxaprozin potassium?
DAYPRO ALTA is a marketed brand name for oxaprozin potassium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of oxaprozin potassium?
oxaprozin potassium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.